Markets Insider: Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company’s newly FDA-approved ... Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect Investing.com Australia: Weight Watchers stock jumps on new Eli Lilly GLP-1 offering Investing.com -- Weight Watchers (NASDAQ:WW) shares rose 17% Thursday after the company announced it will offer Eli Lilly and Company’s newly FDA-approved oral GLP-1 medication Foundayo (orforglipron) ...

Understanding the Context

Forbes: The WeightWatchers Bankruptcy And What It Says About Diet Culture Now From the Weight Watchers app to semaglutide prescriptions, the WW weight loss program is shifting—and its bankruptcy reveals what that means for the future of diet culture. The wellness giant’s ... Weight Watchers has established an interim office of the CEO, with Chief Financial Officer Felicia DellaFortuna and Chief Operations Officer Jon Volkmann serving as principal offi ... FinanzNachrichten.de: WW International Inc.: Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo Available Through LillyDirect WW International, Inc.

Key Insights

(NASDAQ: WW) ("Weight Watchers"), the global leader in science-backed weight management, announced that it is now offering access to ... WW International Inc.: Weight Watchers Launches Eli Lilly and Company's New Oral GLP-1 Foundayo Available Through LillyDirect